HEPION PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Rent
HEPION PHARMACEUTICALS, INC. (HEPA) reported Increase (Decrease) in Prepaid Rent of -$9.23 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidRent · last filed 2020-05-14
- HEPION PHARMACEUTICALS, INC. increase (decrease) in prepaid rent for the quarter ending 2018-12-31 was -$914.00.
- HEPION PHARMACEUTICALS, INC. increase (decrease) in prepaid rent for the quarter ending 2018-09-30 was -$915.00.
- HEPION PHARMACEUTICALS, INC. increase (decrease) in prepaid rent for the quarter ending 2018-06-30 was -$914.00.
- HEPION PHARMACEUTICALS, INC. increase (decrease) in prepaid rent for the quarter ending 2018-03-31 was -$6.49K.
- HEPION PHARMACEUTICALS, INC. increase (decrease) in prepaid rent for fiscal 2018 was -$9.23K.
| Period end | Increase (Decrease) in Prepaid Rent 3 month | Increase (Decrease) in Prepaid Rent 6 month | Increase (Decrease) in Prepaid Rent 9 month | Increase (Decrease) in Prepaid Rent 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$914.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | -$1.83K derived: sum of 2 quarters · filed 2020-05-14 | -$2.74K derived: sum of 3 quarters · filed 2020-05-14 | -$9.23K 10-K · filed 2020-05-14 |
| 2018-09-30 | -$915.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$1.83K derived: sum of 2 quarters · filed 2019-11-14 | -$8.32K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | -$914.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$7.41K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | -$6.49K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |